参考文献/References:
[1]Rossaki FM,Hurst JR,van Gemert F,et al.Strategies for the prevention, diagnosis and treatment of COPD in low- and middle- income countries: the importance of primary care[J].Expert Rev Respir Med,2021,15(12):1563-1577.[2]张冬莹,高怡,简文华,等.肺功能检查技术在基层医疗卫生机构推广可行性及建议[J].中国全科医学,2020,23(29):3638-3643.[3]陈艺萍,何文芳,熊淑云,等.慢性阻塞性肺病患者出院后1个月内再住院的影响因素调查研究[J].护理实践与研究,2020,17(6):4-7.[4]Xu J,Wang X,Li Z,et al.AECOPD research in the past ten years: a bibliographic analysis based on Web of Science[J].Ann Palliat Med,2021,10(10):10401-10413.[5]Wu YK,Lan CC,Tzeng IS,et al.The COPD-readmission (CORE) score: A novel prediction model for one-year chronic obstructive pulmonary disease readmissions[J].J Formos Med Assoc,2021,120(3):1005-1013.[6]Wells G,Shea B,O’Connell D,et al.The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses[J].PLoS Negl Trop Di,2013,5(7):2195-2207.[7]Almagro P,Barreiro B,De EchagüenA O,et al.Risk factors for hospital readmission in patients with chronic obstructive pulmonary disease[J].Respiration,2006,73(3):311-317.[8]Couillard S,Larivée P,Courteau J,et al.Eosinophils in COPD Exacerbations Are Associated With Increased Readmissions[J].Chest,2017,151(2):366-373.[9]Fernández-García S,Represas-Represas C,Ruano-Ravi?觡a A,et al.Social and clinical predictors of short- and long-term readmission after a severe exacerbation of copd[J].PLoS One,2020,15(2):e229257.[10]Gershon AS,Thiruchelvam D,Aaron S,et al.Socioeconomic status (SES) and 30-day hospital readmissions for chronic obstructive pulmonary (COPD) disease: A population-based cohort study[J].PLoS One,2019,14(5):e0216741.[11]Kon SS,Jones SE,Schofield SJ,et al.Gait speed and readmission following hospitalisation for acute exacerbations of COPD: a prospective study[J].Thorax,2015,70(12):1131-1137.[12]Lin J,Xu Y,Wu X,et al.Risk factors associated with chronic obstructive pulmonary disease early readmission[J].Respirology,2013,18:132.[13]Peng J,Yu Q,Fan S,et al.High Blood Eosinophil and YKL-40 Levels, as Well as Low CXCL9 Levels, are Associated with Increased Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Int J Chron Obstruct Pulmon Dis,2021,16:795-806.[14]Rezaee ME,Ward CE,Nuanez B,et al.Examining 30-day COPD readmissions through the emergency department[J].Int J Chron Obstruct Pulmon Dis,2017,13:109-120.[15]Wei X,Ma Z,Yu N,et al.Risk factors predict frequent hospitalization in patients with acute exacerbation of COPD[J].Int J Chron Obstruct Pulmon Dis,2017,13:121-129.[16]Zhou Y,Thanathi Mohamed Ameen MNA,Li W,et al.Main pulmonary artery enlargement predicts 90-day readmissions in Chinese COPD patients[J].J Thorac Dis,2021,13(10):5731-5740.[17]Al Aqqad SMH,Tangiisuran B,Hyder Ali IA,et al.Hospitalisation of multiethnic older patients with AECOPD: exploration of the occurrence of anxiety, depression and factors associated with short-term hospital readmission[J].Clin Respir J,2017,11(6):960-967.[18]杨舒雯.慢性阻塞性肺疾病急性加重患者再入院的相关危险因素分析[D].福州:福建医科大学,2021.[19]周寅川,荣蓉,黄祎丹,等.慢性阻塞性肺疾病急性加重期患者出院后30d内再入院的影响因素分析及Nomogram模型构建[J].实用心脑肺血管病杂志,2020,28(8):57-63.[20]朱梦培.慢性阻塞性肺疾病急性加重期患者的血液学参数与短期再入院风险[D].武汉:华中科技大学,2021.[21]Quintana JM,Esteban C,Garcia-Gutierrez S,et al.Predictors of hospital admission two months after emergency department evaluation of COPD exacerbation[J].Respiration,2014,88(4):298-306.[22]Nantsupawat T,Limsuwat C,Nugent K.Factors affecting chronic obstructive pulmonary disease early rehospitalization[J].Chron Respir Dis,2012,9(2):93-98.[23]Montserrat-Capdevila J,Godoy P,Marsal JR,et al.Predictive Model of Hospital Admission for COPD Exacerbation[J].Respir Care,2015,60(9):1288-1294.[24]Zhu M,Dai L,Wan L,et al.Dynamic Increase of Red Cell Distribution Width Predicts Increased Risk of 30-Day Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Int J Chron Obstruct Pulmon Dis,2021,16:393-400.[25]Hartl S,Lopez-Campos JL,Pozo-Rodriguez F,et al.Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit[J].Eur Respir J,2016,47(1):113-121.[26]Crisafulli E,Torres A,Huerta A,et al.C-Reactive Protein at Discharge, Diabetes Mellitus and ≥ 1 Hospitalization During Previous Year Predict Early Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].COPD,2015,12(3):306-314.[27]Chen L,Chen S.Prediction of readmission in patients with acute exacerbation of chronic obstructive pulmonary disease within one year after treatment and discharge[J].BMC Pulm Med,2021,21(1):320.[28]张瑞,吴珍珍,常艳,等.老年慢性阻塞性肺疾病患者30天内急性加重再入院风险预测模型的构建与验证[J].中国呼吸与危重监护杂志,2021,20(7):457-464.[29]戴路明,刘攸芝,刘凌,等.稳定期及发作期慢性阻塞性肺疾病患者痰液白细胞介素-1β和白细胞介素-6变化[J].中国呼吸与危重监护杂志,2002(1):22-25.[30]Cao Z,Ong KC,Eng P,et al.Frequent hospital readmissions for acute exacerbation of COPD and their associated factors[J].Respirology,2006,11(2):188-195.[31]罗倩,王连红,韩碟,等.老年慢性阻塞性肺疾病患者自我管理知识-态度-行为现状及影响因素的研究[J].中国呼吸与危重监护杂志,2018,17(6):552-556.[32]张静,常春,姚婉贞.慢性阻塞性肺疾病1年内再入院危险因素分析[J].国际呼吸杂志,2014,34(7):500-503.[33]Crisafulli E,Ielpo A,Barbeta E,et al.Clinical variables predicting the risk of a hospital stay for longer than 7?days in patients with severe acute exacerbations of chronic obstructive pulmonary disease: a prospective study[J].Respir Res,2018,19(1):261.[34]Kalemci S,Akin F,Sarihan A,et al.The relationship between hematological parameters and the severity level of chronic obstructive lung disease[J].Pol Arch Intern Med,2018,128(3):171-177.[35]Zhu M,Peng H,Wan L,et al.The role of elevated red blood cell distribution width in the prognosis of AECOPD patients: A retrospective study[J].Medicine,2021,100(10):e25010.[36]Hegewald MJ,Horne BD,Trudo F,et al.Blood Eosinophil Count and Hospital Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Int J Chron Obstruct Pulmon Dis,2020,15:2629-2641.[37]Hegewald MJ,Horne BD,Trudo F,et al.Blood Eosinophil Count and Hospital Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Int J Chron Obstruct Pulmon Dis,2020,15:2629-2641.[38]张霖,皮春梅,聂秀红.查尔森合并症指数对老年慢性阻塞性肺疾病患者预后的评估价值[J].中国呼吸与危重监护杂志,2016,15(4):333-336.
相似文献/References:
[1]钟雪梅,李 黎,米热班·热夏提,等.α1-抗胰蛋白酶与维吾尔族慢性阻塞性肺疾病的相关性分析[J].医学信息,2018,31(02):67.[doi:10.3969/j.issn.1006-1959.2018.02.023]
ZHONG Xue-mei,LI Li,Mirban·rixat,et al.Correlation Analysis of α1-antitrypsin and Uygur Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(13):67.[doi:10.3969/j.issn.1006-1959.2018.02.023]
[2]陈文福.噻托溴铵治疗稳定期慢性阻塞性肺疾病的临床疗效分析[J].医学信息,2018,31(02):124.[doi:10.3969/j.issn.1006-1959.2018.02.045]
CHEN Wen-fu.Clinical Analysis of Tiotropium Bromide in the Treatment of Stable Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(13):124.[doi:10.3969/j.issn.1006-1959.2018.02.045]
[3]吴仲东.无创机械通气用于COPD合并呼吸衰竭的疗效分析[J].医学信息,2018,31(04):106.[doi:10.3969/j.issn.1006-1959.2018.04.036]
WU Zhong-dong.Clinical Analysis of Noninvasive Mechanical Ventilation in Patients with COPD Complicated with Respiratory Failure[J].Journal of Medical Information,2018,31(13):106.[doi:10.3969/j.issn.1006-1959.2018.04.036]
[4]龙有珠.氨茶碱联合呼吸功能训练治疗慢性阻塞性肺疾病的疗效分析[J].医学信息,2018,31(04):127.[doi:10.3969/j.issn.1006-1959.2018.04.045]
LONG You-zhu.Effect of Aminophylline Combined with Respiratory Function Training on Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(13):127.[doi:10.3969/j.issn.1006-1959.2018.04.045]
[5]皮鑫鑫,邓 革.临床药师对1例院内感染患者的病例分析[J].医学信息,2018,31(04):188.[doi:10.3969/j.issn.1006-1959.2018.04.072]
[6]罗 倩.COPD加重期患者肺功能、血气指标及
炎症指标的变化分析[J].医学信息,2018,31(09):114.[doi:10.3969/j.issn.1006-1959.2018.09.034]
LUO Qian.Changes of Pulmonary Function,Blood Gas and Inflammation in Patients with COPD Exacerbation[J].Journal of Medical Information,2018,31(13):114.[doi:10.3969/j.issn.1006-1959.2018.09.034]
[7]赵志国.有创-无创序贯通气疗法治疗慢性阻塞性肺疾病
引发的严重呼吸衰竭的临床研究[J].医学信息,2018,31(11):110.[doi:10.3969/j.issn.1006-1959.2018.11.034]
ZHAO Zhi-guo.Clinical Study of Invasive Non-invasive Sequential Ventilation in Treatment of Severe Respiratory Failure Caused by Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(13):110.[doi:10.3969/j.issn.1006-1959.2018.11.034]
[8]金彦青.NPPV治疗慢性阻塞性肺疾病合并
重症呼吸衰竭的临床疗效观察[J].医学信息,2018,31(14):113.[doi:10.3969/j.issn.1006-1959.2018.14.033]
JIN Yan-qing.Clinical Efficacy of NPPV in the Treatment of Chronic Obstructive Pulmonary Disease with Severe Respiratory Failure[J].Journal of Medical Information,2018,31(13):113.[doi:10.3969/j.issn.1006-1959.2018.14.033]
[9]何冬兰,李 文.NLR、PLR在慢性阻塞性肺疾病进展、预后中的相关研究[J].医学信息,2022,35(11):25.[doi:10.3969/j.issn.1006-1959.2022.11.008]
HE Dong-lan,LI Wen.Study on Correlation Between NLR and PLR in the Progression and Prognosis of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2022,35(13):25.[doi:10.3969/j.issn.1006-1959.2022.11.008]
[10]张 林,白 俐.扶正化瘀胶囊对慢性阻塞性肺疾病患者炎性因子及
MMP-9、TIMP-1的影响[J].医学信息,2018,31(14):152.[doi:10.3969/j.issn.1006-1959.2018.14.047]
ZHANG Lin,BAI Li.Effect of Fuzheng Huayu Capsule on Inflammatory Factors,MMP-9 and TIMP-1 in Patients with Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(13):152.[doi:10.3969/j.issn.1006-1959.2018.14.047]